We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Empire State Realty Trust
ESRT
$836M
| $688K | ﹤0.01% |
62,118
+18,900
| +44% | +$197K |
|
1102
JFrog
FROG
$11.5B
| $688K | ﹤0.01% |
23,700
+8,300
| +54% | +$261K |
|
1103
NMI Holdings
NMIH
$3.42B
| $688K | ﹤0.01% |
16,700
| – | – |
|
|
CPRX
1104
DELISTED
Catalyst Pharmaceutical
CPRX
| $685K | ﹤0.01% |
34,477
+5,500
| +19% | +$102K |
|
|
CWAN
1105
DELISTED
Clearwater Analytics
CWAN
| $684K | ﹤0.01% |
27,100
+8,600
| +46% | +$193K |
|
|
SEM
1106
DELISTED
Select Medical
SEM
| $684K | ﹤0.01% |
36,398
+5,011
| +16% | +$96K |
|
1107
Sotera Health
SHC
$5.43B
| $683K | ﹤0.01% |
40,900
+11,500
| +39% | +$168K |
|
1108
ABM Industries
ABM
$2.82B
| $681K | ﹤0.01% |
12,909
| – | – |
|
1109
PJT Partners
PJT
$4.57B
| $680K | ﹤0.01% |
5,100
+800
| +19% | +$97.8K |
|
1110
Griffon
GFF
$4.8B
| $679K | ﹤0.01% |
9,700
| – | – |
|
1111
Enerpac Tool Group
EPAC
$1.89B
| $678K | ﹤0.01% |
16,174
+3,600
| +29% | +$144K |
|
1112
Full Truck Alliance
YMM
$9.2B
| $677K | ﹤0.01% |
75,100
| – | – |
|
1113
QuidelOrtho
QDEL
$1.03B
| $676K | ﹤0.01% |
14,819
+3,000
| +25% | +$121K |
|
1114
Rapid7
RPD
$929M
| $674K | ﹤0.01% |
16,900
| – | – |
|
|
UCB
1115
United Community Banks
UCB
$4.43B
| $673K | ﹤0.01% |
23,139
| – | – |
|
1116
Virtu Financial
VIRT
$5.05B
| $667K | ﹤0.01% |
21,900
+4,800
| +28% | +$137K |
|
1117
Bread Financial
BFH
$4.51B
| $666K | ﹤0.01% |
14,000
+6,000
| +75% | +$305K |
|
1118
Intellia Therapeutics
NTLA
$1.66B
| $666K | ﹤0.01% |
32,400
+6,300
| +24% | +$145K |
|
|
NARI
1119
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $660K | ﹤0.01% |
16,000
+2,900
| +22% | +$139K |
|
1120
DigitalBridge
DBRG
$2.94B
| $658K | ﹤0.01% |
46,600
+12,000
| +35% | +$159K |
|
1121
MP Materials
MP
$9.91B
| $658K | ﹤0.01% |
37,300
| – | – |
|
1122
Stride
LRN
$3.48B
| $657K | ﹤0.01% |
7,700
| – | – |
|
1123
MoonLake Immunotherapeutics
MLTX
$1.4B
| $655K | ﹤0.01% |
13,000
+2,700
| +26% | +$127K |
|
1124
Vericel Corp
VCEL
$2.28B
| $654K | ﹤0.01% |
15,479
+3,000
| +24% | +$143K |
|
1125
Graham Holdings Company
GHC
$4.97B
| $652K | ﹤0.01% |
793
| – | – |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.